“Comparison of Efficacy of Intravenous Amikacin with Intravenous Cefoparazone/Sulbactum in Urinary Tract Infections Caused by Escherichia Coli Indiabetic Patients”, mfm, vol. 30, no. 8, May 2024, Accessed: Dec. 26, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3756